{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:57:43Z","timestamp":1785308263980,"version":"3.55.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,6,29]],"date-time":"2012-06-29T00:00:00Z","timestamp":1340928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1038\/eye.2012.126","type":"journal-article","created":{"date-parts":[[2012,6,29]],"date-time":"2012-06-29T10:03:29Z","timestamp":1340964209000},"page":"1157-1172","source":"Crossref","is-referenced-by-count":130,"title":["Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture"],"prefix":"10.1038","volume":"26","author":[{"given":"B","family":"Damato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,29]]},"reference":[{"key":"BFeye2012126_CR1","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/eye.2011.272","volume":"26","author":"BE Damato","year":"2012","unstructured":"Damato BE, Coupland SE . Differences in uveal melanomas between men and women from the British Isles. Eye 2012; 26: 292\u2013299.","journal-title":"Eye"},{"issue":"8","key":"BFeye2012126_CR2","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.ophtha.2012.01.048","volume":"119","author":"Erika M. Damato","year":"2012","unstructured":"Damato EM, Damato BE . Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2384 patients. Ophthalmology 2012 e-pub ahead of print 11 April 2012 doi:10.1016\/j.ophtha.2012.01.048.","journal-title":"Ophthalmology"},{"key":"BFeye2012126_CR3","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/eye.1990.51","volume":"4","author":"BE Damato","year":"1990","unstructured":"Damato BE, Foulds WS . Tumour-associated retinal pigment epitheliopathy. Eye 1990; 4: 382\u2013387.","journal-title":"Eye"},{"key":"BFeye2012126_CR4","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/j.ophtha.2008.04.025","volume":"115","author":"SE Coupland","year":"2008","unstructured":"Coupland SE, Campbell I, Damato B . Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability. Ophthalmology 2008; 115: 1778\u20131785.","journal-title":"Ophthalmology"},{"key":"BFeye2012126_CR5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/cncr.11113","volume":"97","author":"S Eskelin","year":"2003","unstructured":"Eskelin S, Pyrh\u00f6nen S, Hahka-Kemppinen M, Tuomaala S, Kivel\u00e4 T . A prognostic model and staging for metastatic uveal melanoma. Cancer 2003; 97: 465\u2013475.","journal-title":"Cancer"},{"key":"BFeye2012126_CR6","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/eye.2010.194","volume":"25","author":"MF Anderson","year":"2011","unstructured":"Anderson MF, Callejo S, Bridson JD, Damato BE . Diagnostic information provided by referrers to patients with suspected uveal melanoma. Eye 2011; 25: 392.","journal-title":"Eye"},{"issue":"2","key":"BFeye2012126_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1258\/ce.2009.009045","volume":"5","author":"JD Bridson","year":"2010","unstructured":"Bridson JD, Damato B . Consent to rapid treatment of eye tumours: is the waiting time too short at Liverpool Ocular Oncology Centre? Clin Ethics 2010; 5 (2): 86\u201394.","journal-title":"Clin Ethics"},{"key":"BFeye2012126_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1001\/archophthalmol.2009.401","volume":"128","author":"EG Feinstein","year":"2010","unstructured":"Feinstein EG, Marr BP, Winston CB, Abramson DH . Hepatic abnormalities identified on abdominal computed tomography at diagnosis of uveal melanoma. Arch Ophthalmol 2010; 128: 319\u2013323.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2012126_CR9","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/eye.1998.204","volume":"12","author":"FG Ah-Fat","year":"1998","unstructured":"Ah-Fat FG, Sharma MC, Damato BE . Taping outpatient consultations: a survey of attitudes and responses of adult patients with ocular malignancy. Eye 1998; 12: 789\u2013791.","journal-title":"Eye"},{"key":"BFeye2012126_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/sj.bjc.6605765","volume":"103","author":"B Damato","year":"2010","unstructured":"Damato B . Does ocular treatment of uveal melanoma influence survival? Br J Cancer 2010; 103: 285\u2013290.","journal-title":"Br J Cancer"},{"key":"BFeye2012126_CR11","volume-title":"A treatise on intraocular tumors, from original clinical observations and anatomical investigations.","author":"H Knapp","year":"1869","unstructured":"Knapp H . A treatise on intraocular tumors, from original clinical observations and anatomical investigations., English translation; (edn) William Wood & Co.: New York, 1869."},{"key":"BFeye2012126_CR12","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/bjo.71.5.348","volume":"71","author":"WA Manschot","year":"1987","unstructured":"Manschot WA, van Strik R . Is irradiation a justifiable treatment of choroidal melanoma? Analysis of published results. Br J Ophthalmol 1987; 71: 348\u2013352.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2012126_CR13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/bjo.62.6.420","volume":"62","author":"LE Zimmerman","year":"1978","unstructured":"Zimmerman LE, McLean IW, Foster WD . Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells. Br JOphthalmol 1978; 62: 420\u2013425.","journal-title":"Br JOphthalmol"},{"key":"BFeye2012126_CR14","doi-asserted-by":"crossref","unstructured":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report no. 28. Arch Ophthalmol 2006; 124: 1684\u20131693.","DOI":"10.1001\/archopht.124.12.1684"},{"key":"BFeye2012126_CR15","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.ajo.2004.07.006","volume":"138","author":"BS Hawkins","year":"2004","unstructured":"Hawkins BS . The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24. Am J Ophthalmol 2004; 138: 936\u2013951.","journal-title":"Am J Ophthalmol"},{"key":"BFeye2012126_CR16","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1001\/archopht.125.7.966","volume":"125","author":"B Damato","year":"2007","unstructured":"Damato B . Legacy of the collaborative ocular melanoma study. Arch Ophthalmol 2007; 125: 966\u2013968.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2012126_CR17","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/S0161-6420(00)00182-2","volume":"107","author":"S Eskelin","year":"2000","unstructured":"Eskelin S, Pyrh\u00f6nen S, Summanen P, Hahka-Kemppinen M, Kivel\u00e4 T . Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology 2000; 107: 1443\u20131449.","journal-title":"Ophthalmology"},{"key":"BFeye2012126_CR18","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/S0140-6736(96)90736-9","volume":"347","author":"G Prescher","year":"1996","unstructured":"Prescher G, Bornfeld N, Hirche H, Horsthemke B, J\u00f6ckel KH, Becher R . Prognostic implications of monosomy 3 in uveal melanoma. Lancet 1996; 347: 1222\u20131225.","journal-title":"Lancet"},{"key":"BFeye2012126_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/ijc.11558","volume":"108","author":"M H\u00f6glund","year":"2004","unstructured":"H\u00f6glund M, Gisselsson D, Hansen GB, White VA, S\u00e4ll T, Mitelman F et al. Dissecting karyotypic patterns in malignant melanomas: temporal clustering of losses and gains in melanoma karyotypic evolution. Int J Cancer 2004; 108: 57\u201365.","journal-title":"Int J Cancer"},{"key":"BFeye2012126_CR20","first-page":"2578","volume":"63","author":"F Tschentscher","year":"2003","unstructured":"Tschentscher F, Husing J, Holter T, Kruse E, Dresen IG, J\u00f6ckel KH et al. Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Cancer Res 2003; 63: 2578\u20132584.","journal-title":"Cancer Res"},{"key":"BFeye2012126_CR21","doi-asserted-by":"publisher","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-10-2076","volume":"16","author":"B Damato","year":"2010","unstructured":"Damato B, Dopierala JA, Coupland SE . Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification. Clin Cancer Res 2010; 16: 6083\u20136092.","journal-title":"Clin Cancer Res"},{"key":"BFeye2012126_CR22","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1001\/archophthalmol.2011.181","volume":"129","author":"SA Callejo","year":"2011","unstructured":"Callejo SA, Dopierala J, Coupland SE, Damato B . Sudden growth of a choroidal melanoma and multiplex ligation-dependent probe amplification findings suggesting late transformation to monosomy 3 type. Arch Ophthalmol 2011; 129: 958\u2013960.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2012126_CR23","first-page":"416","volume":"97","author":"G Meyer Schwickerath","year":"1977","unstructured":"Meyer Schwickerath G, Vogel M . Treatment of malignant melanomas of the choroid by photocoagulation. Trans Ophthalmol Soc UK 1977; 97: 416\u2013420.","journal-title":"Trans Ophthalmol Soc UK"},{"key":"BFeye2012126_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/BF02144128","volume":"224","author":"WS Foulds","year":"1986","unstructured":"Foulds WS, Damato BE . Low-energy long-exposure laser therapy in the management of choroidal melanoma. Graefes Arch Clin Exp Ophthalmol 1986; 224: 26\u201331.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"BFeye2012126_CR25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1001\/archopht.1995.01100030071024","volume":"113","author":"JA Oosterhuis","year":"1995","unstructured":"Oosterhuis JA, Journee-de Korver HG, Kakebeeke-Kemme HM, Bleeker JC . Transpupillary thermotherapy in choroidal melanomas. Arch Ophthalmol 1995; 113: 315\u2013321.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2012126_CR26","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1055\/s-0028-1109514","volume":"226","author":"GE Lang","year":"2009","unstructured":"Lang GE, Mennel S, Spital G, Wachtlin J, Jurklies B, Heimann H et al. Different indications of photodynamic therapy in ophthalmology. Klin Monatsbl Augenheilkd 2009; 226: 725\u2013739.","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"BFeye2012126_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1136\/bjo.14.4.145","volume":"14","author":"RF Moore","year":"1930","unstructured":"Moore RF . Choroidal sarcoma treated by the intraocular insertion of radon seeds. Br J Ophthalmol 1930; 14: 145\u2013152.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2012126_CR28","doi-asserted-by":"crossref","unstructured":"Russo A, Laguardia M, Damato B . Eccentric ruthenium plaque radiotherapy of posterior choroidal melanoma. Graefes Arch Clin Exp Ophthalmol 2012 e-pub ahead of print 28 March 2012; PMID 22460679.","DOI":"10.1007\/s00417-012-1962-3"},{"key":"BFeye2012126_CR29","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.ijrobp.2005.02.059","volume":"63","author":"B Damato","year":"2005","unstructured":"Damato B, Patel I, Campbell IR, Mayles HM, Errington RD . Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas. Int J Radiat Oncol Biol Phys 2005; 63: 392\u2013400.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFeye2012126_CR30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ijrobp.2005.02.017","volume":"63","author":"B Damato","year":"2005","unstructured":"Damato B, Patel I, Campbell IR, Mayles HM, Errington RD . Local tumor control after (106)Ru brachytherapy of choroidal melanoma. Int J Radiat Oncol Biol Phys 2005; 63: 385\u2013391.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFeye2012126_CR31","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.ijrobp.2005.01.016","volume":"62","author":"B Damato","year":"2005","unstructured":"Damato B, Kacperek A, Chopra M, Campbell IR, Errington RD . Proton beam radiotherapy of choroidal melanoma: the Liverpool-Clatterbridge experience. Int J Radiat Oncol Biol Phys 2005; 62: 1405\u20131411.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFeye2012126_CR32","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S0360-3016(97)00557-9","volume":"39","author":"IK Daftari","year":"1997","unstructured":"Daftari IK, Char DH, Verhey LJ, Castro JR, Petti PL, Meecham WJ . Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma. Int J Radiat Oncol Biol Phys 1997; 39: 997\u20131010.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFeye2012126_CR33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ijrobp.2005.01.050","volume":"63","author":"B Damato","year":"2005","unstructured":"Damato B, Kacperek A, Chopra M, Sheen MA, Campbell IR, Errington RD . Proton beam radiotherapy of iris melanoma. Int J Radiat Oncol Biol Phys 2005; 63: 109\u2013115.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFeye2012126_CR34","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2147\/OPTH.S9523","volume":"4","author":"AN Tan","year":"2010","unstructured":"Tan AN, Hoevenaars JG, Webers CA, Damato B, Beckers HJ . Baerveldt implant for secondary glaucoma due to iris melanoma. Clin Ophthalmol 2010; 4: 407\u2013409.","journal-title":"Clin Ophthalmol"},{"key":"BFeye2012126_CR35","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s00417-008-0855-y","volume":"246","author":"EM Damato","year":"2008","unstructured":"Damato EM, Damato B, Sibbring JS, Coupland SE . Ciliary body melanoma with partial deletion of chromosome 3 detected with multiplex ligation-dependent probe amplification. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1637\u20131640.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"BFeye2012126_CR36","first-page":"343","volume":"93","author":"WS Foulds","year":"1973","unstructured":"Foulds WS . The local excision of choroidal melanomata. Trans Ophthalmol Soc UK 1973; 93: 343\u2013346.","journal-title":"Trans Ophthalmol Soc UK"},{"key":"BFeye2012126_CR37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/bjo.80.2.102","volume":"80","author":"BE Damato","year":"1996","unstructured":"Damato BE, Paul J, Foulds WS . Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection. Br J Ophthalmol 1996; 80: 102\u2013108.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2012126_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1136\/bjo.80.2.109","volume":"80","author":"BE Damato","year":"1996","unstructured":"Damato BE, Paul J, Foulds WS . Risk factors for metastatic uveal melanoma after trans-scleral local resection. Br J Ophthalmol 1996; 80: 109\u2013116.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2012126_CR39","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1136\/bjo.77.10.616","volume":"77","author":"BE Damato","year":"1993","unstructured":"Damato BE, Paul J, Foulds WS . Predictive factors of visual outcome after local resection of choroidal melanoma. Br J Ophthalmol 1993; 77: 616\u2013623.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2012126_CR40","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1016\/S0161-6420(02)01240-X","volume":"109","author":"B Damato","year":"2002","unstructured":"Damato B, Groenewald CP, McGalliard JN, Wong D . Rhegmatogenous retinal detachment after transscleral local resection of choroidal melanoma. Ophthalmology 2002; 109: 2137\u20132143.","journal-title":"Ophthalmology"},{"key":"BFeye2012126_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/bjo.82.3.213","volume":"82","author":"B Damato","year":"1998","unstructured":"Damato B, Groenewald C, McGalliard J, Wong D . Endoresection of choroidal melanoma. Br J Ophthalmol 1998; 82: 213\u2013218.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2012126_CR42","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ophtha.2003.05.007","volume":"111","author":"PW Hadden","year":"2004","unstructured":"Hadden PW, Hiscott PS, Damato BE . Histopathology of eyes enucleated after endoresection of choroidal melanoma. Ophthalmology 2004; 111: 154\u2013160.","journal-title":"Ophthalmology"},{"key":"BFeye2012126_CR43","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1136\/bjo.85.1.110e","volume":"85","author":"B Damato","year":"2001","unstructured":"Damato B, Wong D, Green FD, Mackenzie JM . Intrascleral recurrence of uveal melanoma after transretinal \"endoresection\". Br J Ophthalmol 2001; 85: 114\u2013115.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2012126_CR44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/01.iio.0000195856.31324.00","volume":"46","author":"NE Bechrakis","year":"2006","unstructured":"Bechrakis NE, Foerster MH . Neoadjuvant proton beam radiotherapy combined with subsequent endoresection of choroidal melanomas. Int Ophthalmol Clin 2006; 46: 95\u2013107.","journal-title":"Int Ophthalmol Clin"},{"key":"BFeye2012126_CR45","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1055\/s-2006-926654","volume":"223","author":"H Schilling","year":"2006","unstructured":"Schilling H, Bornfeld N, Talies S, Anastassiou G, Sch\u00fcler A, Horstmann GA . [Endoresection of large uveal melanomas after pretreatment by single-dose stereotactic convergence irradiation with the leksell gamma knife--first experience on 46 cases]. Klin Monbl Augenheilkd 2006; 223: 513\u2013520.","journal-title":"Klin Monbl Augenheilkd"},{"key":"BFeye2012126_CR46","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.ophtha.2003.09.028","volume":"111","author":"B Damato","year":"2004","unstructured":"Damato B, Lecuona K . Conservation of eyes with choroidal melanoma by a multimodality approach to treatment: an audit of 1632 patients. Ophthalmology 2004; 111: 977\u2013983.","journal-title":"Ophthalmology"},{"issue":"7","key":"BFeye2012126_CR47","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/eye.2012.62","volume":"26","author":"T Sandinha","year":"2012","unstructured":"Sandinha T, Hebbar G, Kenawy N, Hope-Stone L, Damato B . A nurse-led ocular oncology clinic in Liverpool: results of a 6-month trial. Eye 2012 e-pub ahead of print 20 April 2012; doi:10.1038\/eye.2012.62.","journal-title":"Eye"},{"key":"BFeye2012126_CR48","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.preteyeres.2011.05.003","volume":"30","author":"B Damato","year":"2011","unstructured":"Damato B, Eleuteri A, Taktak AF, Coupland SE . Estimating prognosis for survival after treatment of choroidal melanoma. Prog Retin Eye Res 2011; 30: 285\u2013295.","journal-title":"Prog Retin Eye Res"},{"key":"BFeye2012126_CR49","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/eye.2009.235","volume":"23","author":"B Damato","year":"2009","unstructured":"Damato B, Coupland SE . A reappraisal of the significance of largest basal diameter of posterior uveal melanoma. Eye 2009; 23: 2152\u20132160.","journal-title":"Eye"},{"key":"BFeye2012126_CR50","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/archophthalmol.2009.208","volume":"127","author":"CL Shields","year":"2009","unstructured":"Shields CL, Furuta M, Thangappan A, Nagori S, Mashayekhi A, Lally DR et al. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol 2009; 127: 989\u2013998.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2012126_CR51","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.5858\/133.8.1197","volume":"133","author":"PT Finger","year":"2009","unstructured":"Finger PT . The 7th edition AJCC staging system for eye cancer: an international language for ophthalmic oncology. Arch Pathol Lab Med 2009; 133: 1197\u20131198.","journal-title":"Arch Pathol Lab Med"},{"key":"BFeye2012126_CR52","doi-asserted-by":"crossref","unstructured":"Jmor F, Kalirai H, Taktak A, Damato B, Coupland SE . HSP-27 protein expression in uveal melanoma: correlation with predicted survival. Acta Ophthalmol 2010; 10\u20133768.","DOI":"10.1111\/j.1755-3768.2010.02038.x"},{"key":"BFeye2012126_CR53","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.1194472","volume":"330","author":"JW Harbour","year":"2010","unstructured":"Harbour JW, Onken MD, Roberson ED, Duan S, Cao L, Worley LA et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 2010; 330: 1410\u20131413.","journal-title":"Science"},{"key":"BFeye2012126_CR54","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1111\/j.1755-3768.2009.01769.x","volume":"89","author":"M Angi","year":"2011","unstructured":"Angi M, Damato B, Kalirai H, Dodson A, Taktak A, Coupland SE . Immunohistochemical assessment of mitotic count in uveal melanoma. Acta Ophthalmol 2011; 89: e155\u2013e160.","journal-title":"Acta Ophthalmol"},{"key":"BFeye2012126_CR55","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.ophtha.2007.06.012","volume":"114","author":"B Damato","year":"2007","unstructured":"Damato B, Duke C, Coupland SE, Hiscott P, Smith PA, Campbell I et al. Cytogenetics of uveal melanoma: a 7-year clinical experience. Ophthalmology 2007; 114: 1925\u20131931.","journal-title":"Ophthalmology"},{"key":"BFeye2012126_CR56","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1167\/iovs.12-9584","volume":"53","author":"SL Lake","year":"2012","unstructured":"Lake SL, Kalirai H, Dopierala J, Damato BE, Coupland SE . Comparison of formalin-fixed and snap-frozen samples analyzed by multiplex ligation-dependent probe amplification for prognostic testing in uveal melanoma. Invest Ophthalmol Vis Sci 2012; 53: 2647\u20132652.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye2012126_CR57","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1167\/iovs.08-3165","volume":"50","author":"B Damato","year":"2009","unstructured":"Damato B, Dopierala J, Klaasen A, van Dijk M, Sibbring J, Coupland SE . Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death. Invest Ophthalmol Vis Sci 2009; 50: 3048\u20133055.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye2012126_CR58","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1167\/iovs.09-5004","volume":"51","author":"J Dopierala","year":"2010","unstructured":"Dopierala J, Damato BE, Lake SL, Taktak AF, Coupland SE . Genetic heterogeneity in uveal melanoma assessed by multiplex ligation-dependent probe amplification. Invest Ophthalmol Vis Sci 2010; 51: 4898\u20134905.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye2012126_CR59","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1167\/iovs.02-0159","volume":"44","author":"AG Scholes","year":"2003","unstructured":"Scholes AG, Damato BE, Nunn J, Hiscott P, Grierson I, Field JK . Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. Invest Ophthalmol Vis Sci 2003; 44: 1008\u20131011.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye2012126_CR60","doi-asserted-by":"publisher","first-page":"7205","DOI":"10.1158\/0008-5472.CAN-04-1750","volume":"64","author":"MD Onken","year":"2004","unstructured":"Onken MD, Worley LA, Ehlers JP, Harbour JW . Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 2004; 64: 7205\u20137209.","journal-title":"Cancer Res"},{"key":"BFeye2012126_CR61","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2353\/jmoldx.2010.090220","volume":"12","author":"MD Onken","year":"2010","unstructured":"Onken MD, Worley LA, Tuscan MD, Harbour JW . An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma. J Mol Diagn 2010; 12: 461\u2013468.","journal-title":"J Mol Diagn"},{"key":"BFeye2012126_CR62","first-page":"18","volume":"8","author":"A Eleuteri","year":"2012","unstructured":"Eleuteri A, Damato B, Coupland SE, Taktak AF . Enhancing survival prognostication in patients with choroidal melanoma by integrating pathologic, clinical and genetic predictors of metastasis. Int J Biomed EngTechnol 2012; 8: 18\u201335.","journal-title":"Int J Biomed EngTechnol"},{"key":"BFeye2012126_CR63","first-page":"143","volume":"31","author":"T Hakulinen","year":"1978","unstructured":"Hakulinen T, Teppo L, Saxen E . Cancer of the eye, a review of trends and differentials. World Health Stat Q 1978; 31: 143\u2013158.","journal-title":"World Health Stat Q"},{"key":"BFeye2012126_CR64","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/eye.2008.54","volume":"23","author":"SA Cook","year":"2009","unstructured":"Cook SA, Damato B, Marshall E, Salmon P . Psychological aspects of cytogenetic testing of uveal melanoma: preliminary findings and directions for future research. Eye 2009; 23: 581\u2013585.","journal-title":"Eye"},{"key":"BFeye2012126_CR65","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1001\/archophthalmol.2010.121","volume":"128","author":"IK Kim","year":"2010","unstructured":"Kim IK, Lane AM, Gragoudas ES . Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma. Arch Ophthalmol 2010; 128: 871\u2013875.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2012126_CR66","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1200\/JCO.2004.08.194","volume":"22","author":"M Diener-West","year":"2004","unstructured":"Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD . Screening for metastasis from choroidal melanoma: The Collaborative Ocular Melanoma Study Group Report 23. J Clin Oncol 2004; 22: 2438\u20132444.","journal-title":"J Clin Oncol"},{"key":"BFeye2012126_CR67","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ejso.2009.08.010","volume":"36","author":"V Servois","year":"2010","unstructured":"Servois V, Mariani P, Malhaire C, Petras S, Piperno-Neumann S, Plancher C et al. Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET). Eur J Surg Oncol 2010; 36: 189\u2013194.","journal-title":"Eur J Surg Oncol"},{"key":"BFeye2012126_CR68","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/CMR.0b013e32834d3dcb","volume":"22","author":"V Orcurto","year":"2012","unstructured":"Orcurto V, Denys A, Voelter V et al. (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study. Melanoma Res 2012; 22: 63\u201369.","journal-title":"Melanoma Res"},{"key":"BFeye2012126_CR69","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1007\/s00259-009-1175-0","volume":"36","author":"K Strobel","year":"2009","unstructured":"Strobel K, Bode B, Dummer R, Schalenbourg A, Schnyder P, Zografos L . Limited value of 18F-FDG PET\/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma. Eur J Nucl Med Mol Imaging 2009; 36: 1774\u20131782.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"BFeye2012126_CR70","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/jjco\/hym018","volume":"37","author":"T Maeda","year":"2007","unstructured":"Maeda T, Tateishi U, Suzuki S, Arai Y, Kim EE, Sugimura K . Magnetic resonance screening trial for hepatic metastasis in patients with locally controlled choroidal melanoma. Jpn J Clin Oncol 2007; 37: 282\u2013286.","journal-title":"Jpn J Clin Oncol"},{"key":"BFeye2012126_CR71","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ajo.2009.01.023","volume":"148","author":"JJ Augsburger","year":"2009","unstructured":"Augsburger JJ, Correa ZM, Shaikh AH . Effectiveness of treatments for metastatic uveal melanoma. Am J Ophthalmol 2009; 148: 119\u2013127.","journal-title":"Am J Ophthalmol"},{"key":"BFeye2012126_CR72","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1053\/j.seminoncol.2010.03.014","volume":"37","author":"T Sato","year":"2010","unstructured":"Sato T . Locoregional management of hepatic metastasis from primary uveal melanoma. Semin Oncol 2010; 37: 127\u2013138.","journal-title":"Semin Oncol"},{"key":"BFeye2012126_CR73","first-page":"6343","volume":"9","author":"HR Alexander","year":"2003","unstructured":"Alexander HR, Libutti SK, Pingpank JF, Steinberg SM, Bartlett DL, Helsabeck C . Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver. Clin Cancer Res 2003; 9: 6343\u20136349.","journal-title":"Clin Cancer Res"},{"key":"BFeye2012126_CR74","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.ejso.2009.02.016","volume":"35","author":"P Mariani","year":"2009","unstructured":"Mariani P, Piperno-Neumann S, Servois V, Berry MG, Dorval T . Surgical management of liver metastases from uveal melanoma: 16 years\u2019 experience at the Institut Curie. Eur J Surg Oncol 2009; 35: 1192\u20131197.","journal-title":"Eur J Surg Oncol"},{"key":"BFeye2012126_CR75","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi FS, O\u2019Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363: 711\u2013723.","journal-title":"N Engl J Med"},{"key":"BFeye2012126_CR76","unstructured":"Klingenstein A, Haug AR, Zech CJ, Schaller UC . Radioembolization as locoregional therapy of hepatic metastases in uveal melanoma patients. Cardiovasc Intervent Radiol 2012 e-pub ahead of print 21 April 2011; PMID: 22526099."}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye2012126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2012126","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2012126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:16:15Z","timestamp":1684430175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye2012126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,29]]},"references-count":76,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["BFeye2012126"],"URL":"https:\/\/doi.org\/10.1038\/eye.2012.126","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,29]]}}}